ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation

BACKGROUND: Disease-modifying antirheumatic drug (DMARD)-free remission, the sustained absence of synovitis after DMARD cessation, is increasingly achievable, especially in autoantibody-negative rheumatoid arthritis (RA). However, underlying mechanisms are unknown and patient subgroups that achieve...

Descripción completa

Detalles Bibliográficos
Autores principales: Boeters, Debbie M., Burgers, Leonie E., Sasso, Eric H., Huizinga, Tom W. J., van der Helm – van Mil, Annette H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518725/
https://www.ncbi.nlm.nih.gov/pubmed/31088574
http://dx.doi.org/10.1186/s13075-019-1902-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518725/
https://www.ncbi.nlm.nih.gov/pubmed/31088574
http://dx.doi.org/10.1186/s13075-019-1902-2

Ejemplares similares